Patent · US Active

Evaluating genetic disorders

US10210306B2 · kind B2 · utility

9Cited by
60References
13Claims
0Family size

Assignees

Inventors

Key dates

Filing dateMay 3, 2007
Grant dateFeb 19, 2019
Priority date
Expiry dateOct 29, 2030

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG16B20/20
  • WIPO fieldComputer technology
  • WIPO sectorElectrical engineering

Abstract

The present invention relates to genetic analysis and evaluation utilizing copy-number variants or polymorphisms. The methods utilize array comparative genomic hybridization and PCR assays to identify the significance of copy number variations in a human or non-human animal subject or subject group.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.